A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals

Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
11/2001
11/27/2001	US6323008 Methods for producing sialyloligosaccharides in a dairy source
11/27/2001	US6322781 Production of recombinant baculoviruses
11/22/2001	WO2001088203A1 Cloning of rhadinovirus genome and methods for its use
11/22/2001	WO2001088136A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/22/2001	WO2001088129A1 Anti-angiogenic polypeptides
11/22/2001	WO2001088128A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/22/2001	WO2001088125A1 MUTATION IN THE β2 NICOTINIC ACETYLCHOLINE RECEPTOR SUBUNIT ASSOCIATED WITH NOCTURNAL FRONTAL LOBE EPILEPSY
11/22/2001	WO2001088116A2 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods
11/22/2001	WO2001088115A1 Transgenic caenorhabditis elegans model exhibiting a neuronal dysfunction
11/22/2001	WO2001088109A2 Model for neurodegenerative disease
11/22/2001	WO2001088108A1 Neuronal serine-threonine protein kinase
11/22/2001	WO2001088098A2 Fertilization of aged oocytes
11/22/2001	WO2001088096A2 Ovine tissue for xenotransplantation
11/22/2001	WO2001088087A2 Microfluidic channel embryo and/or oocyte handling, analysis and biological evaluation
11/22/2001	WO2001087980A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/22/2001	WO2001087935A2 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
11/22/2001	WO2001087934A2 Treatment of neoplasia/transformation using a pituitary tumor transforming gene carboxy terminal peptides
11/22/2001	WO2001087059A1 Chimeric animal
11/22/2001	WO2001087058A1 Chimeric mouse having immunity constructed by using human cd34-positive cells and use thereof
11/22/2001	WO2001087057A1 Models of chronic and acute inflammatory diseases
11/22/2001	WO2001087055A2 New screening tool for analyzing the behavior of laboratory animals
11/22/2001	WO2001087039A2 Treatment of neoplasia / transformation using pituitary tumor transforming gene 2
11/22/2001	US20010044937 Transgenic intracytoplasmic sperm injection, retroviral gene transfer, intracytoplasmic nuclear injection, and pronuclear injection; useful as models for human disease/diagnosis, assessing safety and efficiency of drug and gene therapy
11/22/2001	US20010043923 Controlling cell distribution within a bioartificial organ by exposing the cells to a treatment that inhibits cell proliferation, promotes cell differentiation, or affects cell attachment to a growth surface; in vivo implantation
11/22/2001	US20010042520 Method for producing model animals for itching induced by disruption of cutaneous barrier function
11/22/2001	CA2409414A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/22/2001	CA2409108A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/22/2001	CA2409098A1 New screening tool for analyzing the behavior of laboratory animals
11/22/2001	CA2409077A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/22/2001	CA2409075A1 Model for neurodegenerative disease
11/22/2001	CA2408745A1 Anti-angiogenic polypeptides
11/22/2001	CA2408409A1 Models of chronic and acute inflammatory diseases
11/22/2001	CA2408374A1 Mutation in the .beta.2 nicotinic acetylcholine receptor subunit associated with nocturnal frontal lobe epilepsy
11/22/2001	CA2404822A1 Fertilization of aged oocytes
11/21/2001	EP1155148A1 Detection and quantification of micro-organisms using amplification and restriction enzyme analysis
11/21/2001	CN2459889Y Brick for culturing young scorpion
11/21/2001	CN1323354A Characterisation of gene function using double stranded RNA inhibition
11/21/2001	CN1322845A Method for analyzing phylogenetic ancestry of scallop
11/21/2001	CN1322526A Compound for treating female sexual dysfunction
11/21/2001	CN1074900C Biological control of insects
11/20/2001	US6320038 Promoter for neuropeptide FF and use thereof for therapy and diagnostics
11/20/2001	US6319704 Nucleotide sequences coding an enzymatic polypeptide; for use in the diagnosis and treatment of nervous system disorders
11/19/2001	CA2324167A1 A membrane-bound netrin
11/15/2001	WO2001085973A1 Antisense type gene trap vector
11/15/2001	WO2001085939A1 Transgenic animal model by mineralocorticoid receptor antisense expression
11/15/2001	WO2001085938A1 Modified es cells and es cell-specific gene
11/15/2001	WO2001085926A2 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
11/15/2001	WO2001085798A2 Human monoclonal antibodies to dendritic cells
11/15/2001	WO2001085785A2 Ph domain-interacting protein
11/15/2001	WO2001085784A2 POLYNUCLEOTIDES ENCODING FOR POLYMORPHIC ISOFORMS OF THE PTHrP PROTEIN, THE ENCODED PROTEINS AND THEIR THERAPEUTIC APPLICATIONS THEREOF
11/15/2001	WO2001085192A1 Transgenically produced decorin
11/15/2001	WO2001085151A2 Chimeric animal model and treatment of psoriasis
11/15/2001	WO2001084921A2 Transgenic animal
11/15/2001	WO2001084920A1 The production of agricultural animals from embryonic stem (es) cells
11/15/2001	WO2001084919A1 Model systems for neurodegenerative and cardiovascular disorders
11/15/2001	WO2001002550A3 Cell death related drug targets in yeast and fungi
11/15/2001	US20010042256 Genetic engineering
11/15/2001	US20010042255 Nucleic acids
11/15/2001	US20010042254 Polypeptides
11/15/2001	US20010041668 Selecting compound that is functionally equivalent to a gene product expressed in an embryo's extraembryonic tissue, causing the compound to access the cells to stimulate cells to undergo hematopoiesis and vascular growth
11/15/2001	US20010041348 Animal sperm cell membrane
11/15/2001	US20010041178 Preventing airway mucus production by administration of EGF-R antagonists
11/15/2001	CA2408732A1 Modified es cells and es cell-specific gene
11/15/2001	CA2408632A1 Ph domain-interacting protein
11/15/2001	CA2408594A1 Human monoclonal antibodies to dendritic cells
11/15/2001	CA2408559A1 Polynucleotides encoding for polymorphic isoforms of the pthrp protein, the encoded proteins and their therapeutic applications thereof
11/15/2001	CA2408124A1 Transgenically produced decorin
11/15/2001	CA2408051A1 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
11/15/2001	CA2405504A1 Transgenic animal
11/15/2001	CA2379095A1 Antisense gene-trap vector
11/14/2001	EP1153543A1 Animals with insufficient expression of uridine phosphorylase
11/14/2001	EP1153302A1 Diagnostics and therapeutics for macular degeneration
11/14/2001	EP1153301A1 Diagnostics and therapeutics for arterial wall disruptive disorders
11/14/2001	EP1153038A1 Therapeutics and diagnostics based on a il-1b mutation
11/14/2001	EP0652948B1 Development of a vector to target gene expression to the epidermis of transgenic animals
11/14/2001	CN1322214A Induction of antiobiotic proteins and peptides by LAIT/sCD14-protein
11/14/2001	CN1321419A Method for collecting natural living toad slough
11/14/2001	CN1321418A Artificial domestication and scale raising technique of snow chukar
11/13/2001	US6316693 Transgenic mouse model for fatty acid transport
11/13/2001	US6316692 Insertion of nucleotide sequences into genomes; inject sample into testes, recover preferential polypeptide from transformed cells
11/13/2001	US6316691 Atrichia mouse
11/13/2001	US6316690 Non-mammalian transgenic animal model for cellular proliferative diseases
11/13/2001	US6316689 25-hydroxyvitamin D3 24-hydroylase transgenic rats
11/13/2001	US6316222 Binds calcium-signal modulating cyclophilin ligand; use in identifying agents for modulating the calcium induced activation pathway
11/13/2001	US6316203 Methods of screening and preparing a composition using DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
11/13/2001	US6315910 Adding to waste water biological treatment system an effective amount of a water soluble polymer consisting of dialkyl diallyl quaternary ammonium monomers for controlling snails
11/08/2001	WO2001084158A1 Use of the g protein coupled receptor gpr3 to identify appetite control agents
11/08/2001	WO2001083749A2 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners
11/08/2001	WO2001083746A2 Regulatory nucleic acid sequences of the abc1 gene
11/08/2001	WO2001083725A1 Human coagulation factor vii variants
11/08/2001	WO2001083563A2 Method of identifying agents that alter the activity of the promoter sequence for crf receptor 2-alpha
11/08/2001	WO2001083558A1 Agonists/antagonists of the gpr56 receptor as appetite control agents
11/08/2001	WO2001083550A2 Gpr22 modulators as appetite-control agents
11/08/2001	WO2001083524A2 Rna metabolism proteins
11/08/2001	WO2001082688A1 Rab GDI alpha KNOCKOUT ANIMALS
11/08/2001	WO2001034780A3 Cytochrome p450 oxygenases and their uses
11/08/2001	WO2000053775A9 Prevention and treatment of viral infections
11/08/2001	US20010039668 In ovo activation of an egg in the shell
11/08/2001	US20010039667 Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including parkinson's disease
11/08/2001	US20010039666 Non-human mammalian model for atherosclerosis and methods for screening agents for use in the treatment of atherosclerosis

1 ... 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 ... 341